Pharma’s Surefire Formula: Simultaneous Optimization and Reinvention - Inder Sidhu - The Strategy Factory - Forbes
Links shared publicly online about this topic.
- 303total visits
Pharma’s Surefire Formula: Simultaneous Optimization and Reinvention - Inder Sidhu - The Strategy Factory - Forbes
View full resource at blogs.forbes.com
Tags: Drug, Healthcare, Pharma
Most Recently Shared on May 10, 2011 at 5:28 pm By:
Pharma's Surefire Formula: Simultaneous Optimization and Reinvention: Patent expiration, healthcare ref... http://onforb.es/lX4aGa #drug
Biomarkers unbound : Nature Biotechnology : Nature Publishing Group
nature.com — “Controversies surrounding government walk-in rights or patent eligibility that grabbed headlines in recent weeks presage broader changes in biomarker patenting.” View full resource at nature.com
Most Recently Shared on May 12, 2012 at 8:35 pm By:
Walter Jessen, PhD Pharma, Research, PhD, Active Health Library, and Doctor
RT @BiomarkerCOE: Nature Biotechnology editorial on Prometheus & Natco Pharma v. Bayer. Where biomarker IP is heading: http://t.co/C2JXxpGn
The New Pharmacovigilance Legislation Will Impact US And European Drug Manufacturers
medicalnewstoday.com — “The Pharmacovigilance Legislation Will Come into Effect in July As the European Medicines Agency's new PV (pharmacovigilance) Legislation implementation date of July 2012 approac” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2012 at 12:05 pm By:
MNT Med Conferences Health News
The New Pharmacovigilance Legislation Will Impact US And European Drug Manufacturers http://t.co/3cyibCkM #medicalconferences
Gamification and online communities - what can pharma do? | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on May 11, 2012 at 7:47 am By:
Pharmafocus Health News and Pharma
Gamification and online communities - what can pharma do? - http://t.co/OfUacDup
Lyrica fails in diabetes and HIV pain | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on May 9, 2012 at 2:04 pm By:
Pharmafocus Health News and Pharma
Lyrica fails in diabetes and HIV pain - http://t.co/JBtvJMmP
FDA favors first drug for HIV prevention
pharma411.visibli.com — “FDA favors first drug for HIV prevention” View full resource at pharma411.visibli.com
Most Recently Shared on May 8, 2012 at 4:43 pm By:
Richard G. Lanzara Health Professional
RT @pharma411 #pharma FDA favors first drug for HIV prevention http://t.co/t2hTTjRX #biotech #medicine #health #healthcare #publichealth
Drug-making plant blooms : Nature News & Comment
nature.com — “Approval of a ‘biologic’ manufactured in plant cells may pave the way for similar products.” View full resource at nature.com
Most Recently Shared on May 8, 2012 at 3:52 pm By:
Richard G. Lanzara Health Professional
RT @NatureNews Drug-making plant blooms http://t.co/4Sr5XxAL #science #biology #pharma #biotech
Docs riled by FDA's proposal to open up drug access - FiercePharma
fiercepharma.com — “Docs riled by FDA's proposal to open up drug access - FiercePharma” View full resource at fiercepharma.com
Most Recently Shared on May 8, 2012 at 3:15 pm By:
Sermo Team Health Social Media
#Docs riled by FDA's proposal to open up drug access http://t.co/FkHW97Y6 What effects do you think the #FDA change could have on patients?
Abbott Labs To Pay $1.5B Over Anti-Seizure Drug Depakote : NPR
npr.org — “The company admitted that it marketed Depakote for unapproved uses, including treatment of schizophrenia, agitated dementia and autism. The case includes a criminal fine and forfeiture of $700 million and civil settlements with the federal government and states totaling $800 million.” View full resource at npr.org
Most Recently Shared on May 8, 2012 at 2:04 pm By:
Richard G. Lanzara Health Professional
Via @nprnews: Abbott Labs To Pay $1.5B Over Anti-Seizure Drug http://t.co/znWgC6CL #health #medicine #pharma
Identifying Drugs That Could Help Fight Broad Range Of Viruses
medicalnewstoday.com — “Results of a new study demonstrate the feasibility of a novel strategy in drug discovery: screening large numbers of existing drugs - often already approved for other uses - to see which ones acti” View full resource at medicalnewstoday.com
Most Recently Shared on May 8, 2012 at 7:05 am By:
MNT Pharma News Health News and Pharma
Identifying Drugs That Could Help Fight Broad Range Of Viruses http://t.co/zEsiAVO1 #pharma #pharmaceutical
New technique could identify drugs that help fight broad range of viruses
labspaces.net — “Results of a new study demonstrate the feasibility of a novel strategy in drug discovery: screening large numbers of existing drugs — often already approved for other uses — to see which ones activate genes that boost natural immunity.” View full resource at labspaces.net
Most Recently Shared on May 7, 2012 at 3:45 pm By:
New technique could identify drugs that help fight broad range of viruses - http://t.co/XLIadNIg
Phase 3 Trial Update of Latuda for Bipolar I Depression - MPR
empr.com — “Dainippon Sumitomo Pharma announced results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of Latuda (lurasidone; Sunovion) as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression (PREVAIL 1 and PREVAIL 2; PRogram to EValuate the Antidepressant Impact of Lurasidone).” View full resource at empr.com
Most Recently Shared on May 7, 2012 at 2:27 pm By:
Phase 3 Trial Update of #Latuda for #Bipolar I #Depression http://t.co/qSy2y0ba
Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression
news-medical.net — “Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression (PREVAIL 1 and PREVAIL 2; PRogram to EValuate the Antidepressant Impact of Lurasidone).” View full resource at news-medical.net
Most Recently Shared on May 7, 2012 at 1:48 pm By:
Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression: Dainippon Sumitomo Pha... http://t.co/8V8xkekJ
Medical News: DC Week: NIH, Pharma Join Forces - in Washington-Watch, Washington Watch from MedPage Today
medpagetoday.com — “Medical News: DC Week: NIH, Pharma Join Forces - in Washington-Watch, Washington Watch from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on May 6, 2012 at 12:01 am By:
HealthTrendster Health Executive
DC Week: NIH, Pharma Join Forces: WASHINGTON (MedPage Today) -- The National Institutes of… http://t.co/7Auf2M0c
Bioprocessing | With a Full Range of Products, EMD Millipore Turns Its Attention to Solutions | Pharmaceutical Manufacturing
pharmamanufacturing.com — “The company aims to leverage the expertise it has always had in-house, yet hadn?t fully capitalized on with the pharma industry, says VP Christophe Couturier.” View full resource at pharmamanufacturing.com
Most Recently Shared on May 4, 2012 at 7:01 pm By:
Paul W. Thomas Health Communicator
EMD Millipore's Christophe Couturier on expansion of co's services biz: http://t.co/5xplQKk0 #biopharma @emdmilliporebio @EMDMilliporePS
Healthcare, etc.: Press coverage of health data: Just like Pharma's DTC?
evimedgroup.blogspot.com — “All things healthcare (and some other stuff on occasion)” View full resource at evimedgroup.blogspot.com
Most Recently Shared on May 4, 2012 at 1:01 pm By:
Marya Zilberberg, MD Doctor, Internist, and Physician
New post: Press coverage of health news: Just like Pharma's DTC? http://t.co/c5BlWWKm #methods #observationaldata
Advertisement
